Across 4753 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by 차광렬, Executive. Director active across 2 companies, notably 차바이오텍. Aggregated, 18,471 reports have been recorded. History available since 24 February 2026. The latest transaction was filed on 26 February 2026 (Purchase). Regulator: DART (FSS). The full history is free.
Cha Kwang-ryeol is an Executive at Cha Bio Tech, a company specializing in biotechnology. In his role, he contributes to managing operations and implementing the company's strategies. His expertise in the sector enables him to play a key role in developing innovative solutions.